|
Outcome measures (number of SR) | Condition (number of SR) | CHM | First author | Number of RCTs/total | Conclusion | Risk of publication bias |
|
Primary Endpoints |
Mortality (7) | MI (6) | Shenmai injection | Zeng (2010) [7] | 13/13 | A | H |
Danshen preparations | Wu (2008) [8] | 6/6 | B | NA |
Shengmai injection | Gao (2008) [9] | 4/4 | A | NA |
Yiqi huoxue patent medicine | Zhang (2008) [10] | 9/28 | B | NA |
Herbal injection products | Zhen (2007) [11] | 5/15 | A | H |
Herbal products | Lin (2006) [12] | 4/8 | B | L |
Angina pectoris (1) | Tongxinluo capsule | Wu (2006) [13] | 1/18 | B | H |
|
AMI (6) | MI (2) | Yiqi huoxue patent medicine | Zhang (2008) [10] | 1/28 | B | NA |
Herbal products | Lin (2006) [12] | 2/8 | A | L |
Angina pectoris (4) | Compound salvia pellet | Zhang (2008) [14] | 1/17 | B | H |
Puerarin | Wang (2008) [15] | 1/11 | B | H |
Tongxinluo capsule | Wu (2006) [13] | 3/18 | B | NA |
Dengzhanhua injection | Cao (2005) [16] | 1/8 | A | NA |
|
Restenosis after PCI (1) | CHD (1) | Herbal products | Ren (2008) [17] | 17/17 | A | H |
Recanalization (2) | MI (2) | Yiqi huoxue patent medicine | Zhang (2008) [10] | 7/28 | B | NA |
Herbal injection products | Zhen (2007) [11] | 15/15 | A | NA |
|
Secondary Endpoints (ECG) |
| | | | | | |
ECG (34) | CHD (4) | Shuyu zaogan tablets | Zhang (2011) [18] | 29/32 | A | L |
Kudiezi injection | Zuo (2011) [19] | 15/16 | A | H |
Angina pectoris (30) | Sodium tanshinone IIA Sulfonate | Wang (2011) [20] | 17/29 | A | H |
Danhong injection | Xu (2011) [21] | 19/19 | A | H |
Tongxinluo capsule and compound salvia pellet | Jia (2011) [22] | 65/58 | A | L |
Xuefuzhuyu Decoction | Cui (2011) [23] | 8/10 | A | H |
Shengmai injection | Zhang (2010) [24] | 8/13 | A | H |
Safflower Injection | Wu (2010) [25] | 2/6 | B | NA |
Herbal products | Zhuo (2010) [26] | 3/3 | A | NA |
Tongxinluo capsule | Hao (2010) [27] | 18/20 | A | L |
Gingko | Zha (2010) [28] | 36/50 | A | L |
Gingko | Zhao (2010) [29] | 9/23 | A | L |
Xuefuzhuyu decoction | Song (2010) [30] | 3/3 | A | H |
Xinkeshu | Chen (2010) [31] | 12/18 | A | H |
Yiqihuoxue | Long (2009) [32] | 25/30 | A | H |
Compound salvia pellet | Zhang (2009) [33] | 5/8 | A | L |
Compound salvia pellet | Zhang (2008) [14] | 10/17 | A | H |
Shexiang baoxin wan | Lin (2008) [34] | 20/22 | A | L |
Puerarin | Wang (2008) [15] | 6/11 | A | H |
Suxiao jiuxin wan | Wang (2008) [35] | 14/14 | A | L |
Suxiao jiuxin wan | Duan (2008) [36] | 3/15 | A | H |
Tong xin luo Capsule | He (2007) [37] | 12/17 | A | H |
| Compound salvia pellet | Jiang (2007) [38] | 26/34 | A | H |
Danshen preparations | Li (2007) [39] | 7/13 | A | L |
Compound preparation of salvia miltiorrhiza | Zhang (2007) [40] | 30/33 | A | H |
Danshen preparations | Li (2007) [41] | 20/21 | A | H |
Rhodiola L. | Wang (2006) [42] | 7/8 | A | L |
Tetramethylpyrazine | Zhang (2006) [43] | 10/10 | A | L |
Tongxinluo capsule | Wu (2006) [13] | 10/18 | A | NA |
Puerarin injection | Wang (2006) [44] | 17/20 | A | H |
Compound salvia pellet | Wang (2006) [45] | 27/27 | A | L |
Dengzhanhua injection | Cao (2005) [16] | 8/8 | A | NA |
Compound salvia pellet | Wang (2004) [46] | 17/17 | A | L |
Compound salvia pellet | Zhang (2004) [47] | 19/22 | A | L |
|
Secondry Endpoints (Angina Pectoris) |
| | Shuyu zaogan tablets | Zhang (2011) [18] | 21/22 | A | L |
Angina pectoris (30) | CHD (3) | Shengmai injection | Zhang (2010) [24] | 10/13 | A | H |
| Compound salvia pellet | Zhang (2009) [33] | 8/8 | A | L |
| Sodium tanshinone IIA Sulfonate | Wang (2011) [20] | 29/29 | A | H |
| Danhong injection | Xu (2011) [21] | 19/19 | A | H |
| Tongxinluo capsule and compound salvia pellet | Jia (2011) [22] | 65/65 | A | L |
| Kudiezi injection | Zuo (2011) [19] | 16/16 | A | H |
| Shuxuetong | Li (2010) [48] | 11/13 | A | L |
| Herbal products | Zhuo (2010) [26] | 3/3 | B | NA |
| Tongxinluo capsule | Hao (2010) [27] | 20/20 | A | L |
| Xinkeshu | Chen (2010) [31] | 16/18 | A | H |
| Xuefuzhuyu decoction | Song (2010) [30] | 3/3 | A | H |
| Gingko damo injection | Zha (2010) [28] | 46/50 | A | L |
| Ginkgo extract | Zhao (2010) [29] | 22/23 | A | L |
| Suxiao jiuxin wan | Duan (2008) [36] | 1/15 | A | H |
Angina pectoris (26) | Puerarin | Wang (2008) [15] | 10/11 | A | H |
| Suxiao jiuxin wan | Wang (2008) [35] | 14/14 | A | L |
| Compound salvia pellet | Zhang (2008) [14] | 11/17 | A | H |
| Compound salvia pellet | Jiang (2007) [38] | 34/34 | A | H |
| Compound preparation of salvia miltiorrhiza | Zhang (2007) [40] | 32/33 | A | H |
| Danshen preparations | Li (2007) [41] | 21/21 | B | H |
| Tetramethylpyrazine | Zhang (2006) [43] | 8/10 | A | L |
| Rhodiola L. | Wang (2006) [42] | 5/8 | A | L |
| Tongxinluo capsule | Wu (2006) [13] | 5/18 | A | NA |
| Compound salvia pellet | Wang (2006) [45] | 27/27 | A | L |
| Puerarin injection | Wang (2006) [44] | 18/20 | A | H |
| Dengzhanhua injection | Cao (2005) [16] | 8/8 | A | NA |
| Compound salvia pellet | Wang (2004) [46] | 17/17 | A | L |
| Compound salvia pellet | Zhang (2004) [47] | 20/22 | A | L |
CHD after PCI (1) | Herbal products | Ren (2008) [17] | 15/17 | A | H |
|
Secondry End points (Others) |
Consumption of nitroglycerine (5) | Angina pectoris (5) | Herbal products | Zhuo (2010) [26] | 2/3 | A | NA |
| | Suxiao jiuxin wan | Duan (2008) [36] | 1/15 | A | H |
| | Rhodiola L. | Wang (2006) [42] | 1/8 | A | L |
| | Puerarin injection | Wang (2006) [44] | 6/20 | A | H |
| | Tongxinluo capsule | Wu (2006) [13] | 1/18 | A | NA |
|
Level of blood lipids (4) | Angina pectoris (3) | Shuxuetong | Li (2010) [48] | 4/13 | A | H |
| | Compound salvia pellet | Zhang (2008) [14] | 8/22 | B | L |
| | Compound salvia pellet | Zhang (2004) [47] | 4/8 | A | L |
| CHD (1) | Compound salvia pellet | Zhang (2009) [33] | 4/17 | A | L |
|
Hemorheology (2) | Angina pectoris (1) | Safflower Injection | Wu (2010) [25] | 2/6 | A | NA |
| CHD (1) | Shengmai injection | Zhang (2010) [24] | 5/13 | A | H |
|
Heart failure (3) | MI (3) | Yiqi huoxue patent medicine | Zhang (2008) [10] | 7/28 | B | NA |
| | Danshen preparations | Wu (2008) [8] | 1/6 | B | NA |
| | Herbal products | Lin (2006) [12] | 3/8 | A | L |
|
Arrhythmia (2) | MI (2) | Yiqi huoxue patent medicine | Zhang (2008) [10] | 2/28 | B | NA |
| Herbal products | Lin (2006) [12] | 2/8 | B | L |
|
UCG (2) | MI (2) | Yiqi huoxue herbal products | Song (2008) [49] | 3/3 | A | NA |
| Herbal products | Lin (2006) [12] | 4/8 | A | L |
|
Myocardial enzyme (1) | Angina pectoris (1) | Tongxinluo capsule | Wu (2006) [13] | 1/18 | B | NA |
|
Level of plasma endothelin (2) | Angina pectoris (2) | Puerarin injection | Wang (2006) [44] | 2/20 | A | H |
| Tongxinluo capsule | Wu (2006) [13] | 4/18 | A | NA |
|
Level of nitric oxide (1) | Angina pectoris (1) | Tongxinluo capsule | Wu (2006) [13] | 2/18 | A | NA |
|
Heart rate variability (1) | CHD (1) | Compound salvia pellet | Zhang (2009) [33] | 3/8 | A | L |
|
TCM syndrome (1) | Angina pectoris (1) | Safflower Injection | Wang (2006) [25] | 3/8 | A | L |
|